ICRG is bringing Intelligence in Scientific Cancer Research, Development, and Organization for the MENA region (Middle-East, North-Africa) and Europe.
ICRG is based on a flexible and reactive organization with an effective and agile structure, ensuring a high level of operational efficiency in all projects implemented.
ICRG is developing cancer research based on the concept of Singularity through specific collaborations with the Max Planck Institute, Garching / Ludwig Maximilians University (MPQ/LMU) (Quantum Optics Program), Munich (Germany), King Saud University, Riyadh, Kingdom of Saudi Arabia (KSA) and King Abdallah University of Science and Technology (KAUST), Thuwal (KSA) (Artificial Intelligence and supercomputing) and clinical research centers in the MENA region led by King Saud University Medical City (KSUMC), Riyadh (KSA), as well as centers in Europe (France).
ICRG is acting on the entire cancer research value chain: clinical, translational and biological research, identification of key research questions, formulation of trials, diagnosis, and definition of target populations, clinical and translational operations, data management, analysis and publication of results, speed of execution as well as training of investigators and support research staff, support programs for patients and anticipating the future.
ICRG is federating, supporting, and coordinating Key Cancer Stakeholders, including key opinion leaders (KOL) in the MENA region in terms of oncology research projects with high added value. ICRG aims to build MENA as a new power on the worldwide oncology scene. It is the first time in the history of cancer research that the MENA region has the opportunity to build research processes able to compete with the West at the highest level. The scientific and operational knowledge of ICRG experts will help to emulate the potential leadership of investigators in participating in cancer centers in the MENA region.
Leading MENA towards excellence in Cancer Research.
Planting the research tree for posterity.